OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Recent Developments in Prostate Cancer

April 5th 2011

Dr. Dreicer Talks About the State of the Healthcare System

April 5th 2011

Hormonal and Radiation Therapy in Prostate Cancer

April 5th 2011

Dr. Dreicer Remarks on Healthcare Reform

April 4th 2011

Healthcare Reform

Dr. Dreicer on Disparities in the Healthcare System

April 4th 2011

Disparities in the Healthcare System

TAK-700 in Localized Prostate Cancer Clinical Trials

April 4th 2011

Dr. Howard Sandler from Cedars-Sinai Medical Center discusses the TAK-700 in Localized Prostate Cancer Clinical Trials

Dr. Twelves on the Value of the Iniparib Trial Results

April 1st 2011

Christopher Twelves, MD, Professor of Clinical Cancer Pharmacology and Oncology and Head of the Clinical Cancer Research Group at the University of Leeds in the United Kingdom on the Value of the Negative Iniparib Trial Results

Dr. Twelves on Negative Phase III Iniparib Announcements

April 1st 2011

Dr. Twelves Describes Iniparib Clinical Trials

April 1st 2011

Dr. Gomella on Jefferson's Multidisciplinary Cancer Center

March 31st 2011

Dr. Dreicer on the Need to Diagnose and Treat Efficiently

March 31st 2011

Dr. Sandler on Clinical Trials for Liase Inhibitors

March 31st 2011

Dr. Dreicer on Newer Prostate Therapy Survival Benefits

March 30th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, Discusses How New Treatments Have Improved Survival

Dr. Gomella on Current Prostate Screening Procedures

March 30th 2011

In an interview at the 2011 IPCC Meeting in New York, Leonard G. Gomella, MD, from Jefferson Kimmel Cancer Center, discusses prostate cancer screening procedures.

Dr. Sandler on Guideline Compliant Care

March 30th 2011

Howard M. Sandler, MD, MS from Cedars-Sinai Medical Center, on Guideline Compliant Care

Dr. Dreicer on Prostate Cancer Combination Therapy

March 29th 2011

Robert Dreicer, MD, from the Taussig Cancer Institute, discusses the various treatments that prostate cancer patients may receive in combination.

Dr. Sandler on Candidates for Liase Inhibitor Clinical Trials

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses candidates for liase inhibitor clinical trials.

Traditional LHRH Agonists Versus Newer Drugs

March 29th 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, compares the efficacy of the mechanism of action for traditional LHRH agonists to newer androgen deprivation therapies

Dr. Petrylak Explains Prostate Cancer Clinical Trial Difficulties

March 28th 2011

Daniel P. Petrylak, MD, from Columbia University Medical Center Explains the Difficulties Facing During Prostate Cancer Clinical Trials

Dr. Kris on the EML4-ALK Translocation in Lung Cancer

March 25th 2011

Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York on the EML4-ALK Translocation